Medpace outlines 2026 revenue growth of up to 12.8% amid backlog normalization and metabolic trial shifts [Seeking Alpha]
Medpace Holdings, Inc. (MEDP)
Last medpace holdings, inc. earnings: 4/28 04:15 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.medpace.com
Company Research
Source: Seeking Alpha
Backlog cancellations in absolute and percent terms were the highest they've been in over a year. This resulted in a lower than Newsletters for Every Investor Get daily, sector-specific newsletters packed with expert insights, fresh ideas, and new opportunities. Subscribe to Newsletters Sign Up Quick Insights Elevated cancellations, especially in metabolic trials, have introduced uncertainty into near-term performance with backlog cancellations reaching their highest level in over a year. Management believes these high cancellations may normalize and maintains a positive outlook for revenue growth in 2026, but acknowledges the risk and admits the outcome will depend on future trends. Medpace expects higher reimbursable costs as a percentage of revenue in 2026, which along with a shift away from high-margin direct service revenue, is anticipated to pressure EBITDA margins. Fourth quarter and full-year margins already showed a slight decrease, and management projects a fla
Show less
Read more
Impact Snapshot
Event Time:
MEDP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MEDP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MEDP alerts
High impacting Medpace Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
MEDP
News
- Medpace Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- Medpace Holdings Inc (MEDP) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... [Yahoo! Finance]Yahoo! Finance
- Medpace (NASDAQ:MEDP) was upgraded by analysts at Robert W. Baird from a "neutral" rating to an "outperform" rating. They now have a $564.00 price target on the stock.MarketBeat
- Medpace Holdings, Inc. (MEDP) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Medpace Holdings: Great Quarter, Stale Backlog, Full Valuation [Seeking Alpha]Seeking Alpha
MEDP
Earnings
- 2/9/26 - Beat
MEDP
Sec Filings
- 2/10/26 - Form 10-K
- 2/9/26 - Form 8-K
- 1/5/26 - Form 4
- MEDP's page on the SEC website